Screener
Eligibility screening
NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
1 US site in OH
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.